XELJANZ XR
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0069-0501 -
Package NDC
0069-0501-30 -
Application number
NDA208246 -
SPL ID
4357a51c-e574-4cc6-96ef-9b9ee02aea1d -
SPL set ID
cf74ba2f-afc5-4baa-8594-979c889a5831 -
UNII
O1FF4DIV0D -
RxCUI
1357541 -
RxCUI
1357547 -
RxCUI
1741046 -
RxCUI
1741049 -
RxCUI
2048566 -
RxCUI
2048568 -
RxCUI
2273113 -
RxCUI
2273115 -
RxCUI
2478433 -
RxCUI
2478437
What the source publishes
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Active ingredients
- tofacitinib
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "XELJANZ XR",
"splId": "4357a51c-e574-4cc6-96ef-9b9ee02aea1d",
"labels": [
{
"setId": "cf74ba2f-afc5-4baa-8594-979c889a5831",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cf74ba2f-afc5-4baa-8594-979c889a5831"
}
],
"routes": [
"ORAL"
],
"labeler": "Pfizer Laboratories Div Pfizer Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-30)",
"package_ndc": "0069-0501-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20160307"
}
],
"productId": "0069-0501_4357a51c-e574-4cc6-96ef-9b9ee02aea1d",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
"productNdc": "0069-0501",
"deaSchedule": null,
"genericName": "tofacitinib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TOFACITINIB CITRATE",
"strength": "11 mg/1"
}
],
"applicationNumber": "NDA208246",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160307",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0300691002018",
"0300691001011"
],
"unii": [
"O1FF4DIV0D"
],
"rxcui": [
"1357541",
"1357547",
"1741046",
"1741049",
"2048566",
"2048568",
"2273113",
"2273115",
"2478433",
"2478437"
],
"spl_set_id": [
"cf74ba2f-afc5-4baa-8594-979c889a5831"
],
"manufacturer_name": [
"Pfizer Laboratories Div Pfizer Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0069-0501_4357a51c-e574-4cc6-96ef-9b9ee02aea1d"